Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup ; volume:10 ; number:1 ; day:16 ; month:8 ; year:2018 ; pages:1-14 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (16.8.2018), 1-14, 12.2018
- Creator
-
Woollacott, Ione O. C.
- Contributor
-
Nicholas, Jennifer M.
Heslegrave, Amanda
Heller, Carolin
Foiani, Martha S.
Dick, Katrina M.
Russell, Lucy L.
Paterson, Ross W.
Keshavan, Ashvini
Fox, Nick C.
Warren, Jason D.
Schott, Jonathan M.
Zetterberg, Henrik
Rohrer, Jonathan D.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0405-8
- URN
-
urn:nbn:de:101:1-2018090312000951207232
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Woollacott, Ione O. C.
- Nicholas, Jennifer M.
- Heslegrave, Amanda
- Heller, Carolin
- Foiani, Martha S.
- Dick, Katrina M.
- Russell, Lucy L.
- Paterson, Ross W.
- Keshavan, Ashvini
- Fox, Nick C.
- Warren, Jason D.
- Schott, Jonathan M.
- Zetterberg, Henrik
- Rohrer, Jonathan D.
- SpringerLink (Online service)
Other Objects (12)
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Sex influences clinical phenotype in frontotemporal dementia
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Prodromal frontotemporal dementia: clinical features and predictors of progression
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Sex influences clinical phenotype in frontotemporal dementia
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Prodromal frontotemporal dementia: clinical features and predictors of progression
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Sex influences clinical phenotype in frontotemporal dementia
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Prodromal frontotemporal dementia: clinical features and predictors of progression